Investing.com - J&J reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
J&J announced earnings per share of $2.6 on revenue of $23.34B. Analysts polled by Investing.com anticipated EPS of $2.36 on revenue of $23.66B.
J&J shares are up 1% from the beginning of the year and are trading at $160.12 , down-from-52-week-high.They are under-performing the S&P Global 100 which is up 16.88% from the start of the year.
J&J follows other major Healthcare sector earnings this month
J&J's report follows an earnings missed by Koninklijke Philips ADR on Monday, who reported EPS of $0.4641 on revenue of $4.82B, compared to forecasts EPS of $0.4775 on revenue of $4.87B.
Helen of Troy Ltd had beat expectations on Thursday, October 7, 2021 with second quarter EPS of $2.65 on revenue of $475.23M, compared to forecast for EPS of $2.25 on revenue of $424.64M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar